Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie.
Looking at options history for AbbVie ABBV we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $316,131 and 5, calls, for a total amount of $572,360.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $200.0 for AbbVie over the recent three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AbbVie's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale activity within a strike price range from $80.0 to $200.0 in the last 30 days.
AbbVie Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | TRADE | BULLISH | 01/16/26 | $100.0 | $98.05 | $100.0 | $80.00 | $340.0K | 0 | 34 |
| ABBV | PUT | SWEEP | BULLISH | 06/20/25 | $1.69 | $1.68 | $1.68 | $150.00 | $151.6K | 3.6K | 1 |
| ABBV | PUT | SWEEP | BULLISH | 06/20/25 | $2.34 | $2.18 | $2.33 | $155.00 | $108.3K | 2.3K | 0 |
| ABBV | CALL | SWEEP | BEARISH | 05/16/25 | $10.55 | $10.3 | $10.3 | $175.00 | $103.0K | 3.0K | 68 |
| ABBV | PUT | TRADE | BEARISH | 01/16/26 | $28.25 | $27.5 | $28.08 | $200.00 | $56.1K | 998 | 20 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Current Position of AbbVie
- Currently trading with a volume of 559,562, the ABBV's price is up by 1.11%, now at $179.44.
- RSI readings suggest the stock is currently may be oversold.
- Anticipated earnings release is in 10 days.
What The Experts Say On AbbVie
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $217.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $241. * In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral, setting a price target of $194.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
